SHAMIKA SPENCER: Open Payments
NPI 1225451784 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,132 in 26 payments from 12 companies in 2025. Trend: 2023 $925 · 2024 $1,270 · 2025 $1,132
Food & beverage: $1,132
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $303 |
| Novo Nordisk Inc | 3 | $159 |
| AstraZeneca Pharmaceuticals LP | 4 | $154 |
| Medtronic, Inc. | 2 | $141 |
| Kestra Medical Technology Services, Inc. | 3 | $124 |
| Abbott Laboratories | 3 | $65 |
| Alnylam Pharmaceuticals Inc. | 2 | $56 |
| CVRx, Inc. | 2 | $50 |
| GENZYME CORPORATION | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: JARDIANCE, IN.PACT ADMIRAL, Assure WCD, Ozempic, LOKELMA, ONPATTRO, Barostim Neo System, Wegovy.
Industry payments across FL — which companies pay providers there.
